HCO32 and HCO27 and related examples
View Patent ↗The instant invention relates to transgenic non-human animals capable of producing heterologous antibodies, transgenes used to produce such transgenic animals, transgenes capable of functionally rearranging a heterologous D gene in V-D-J recombination, immortalized B-cells capable of producing heterologous antibodies, methods and transgenes for producing heterologous antibodies of multiple isotypes, methods and transgenes for producing heterologous antibodies wherein a variable region sequence comprises somatic mutation as compared to germline rearranged variable region sequences, transgenic nonhuman animals which produce antibodies having a human primary sequence and which bind to human antigens, hybridomas made from B cells of such transgenic animals, and monoclonal antibodies expressed by such hybridomas.
1. A bacterial artificial chromosome for use in the preparation of transgenic non-human mammals capable of producing human immunoglobulin, the bacterial artificial chromosome comprising, in operable linkage, an unrearranged human IgM locus sequence in germline configuration that begins about 22 kilobases upstream of variable heavy chain region gene V H 6-1 and extends about 8.6 kilobases downstream of an IgHγ1 constant region gene, operably linked to a synthetic tripartite IgH enhancer comprising human enhancer elements Hs3, Hs1,2 and Hs4.
2. A non-human animal that carries the bacterial artificial chromosome according to claim 1 .
3. The non-human animal according to claim 2 , which is a rodent.
4. The non-human animal according to claim 3 , wherein the rodent is a mouse.
5. A transgenic mouse containing, integrated into its genome, the bacterial artificial chromosome according to claim 1 .
6. A transgenic mouse according to claim 5 , wherein the mouse is cross-bred to the Balb/c strain.
7. A method of producing human antibodies having desired properties from a transgenic mouse, the method comprising:
contacting the transgenic mouse with a pre-selected antigen; and
collecting human antibodies that bind to the pre-selected antigen, wherein the transgenic mouse carries in its genome:
(i) a bacterial artificial chromosome comprising, in operable linkage, an unrearranged human IgM locus sequence in germline configuration that begins about 22 kilobases upstream of variable heavy chain region gene V H 6-1 and extends about 8.6 kilobases downstream of an IgHγ1 constant region gene, operably linked to a synthetic tripartite IgH enhancer comprising human enhancer elements Hs3, Hs1,2 and Hs4; and
(ii) a human immunoglobulin light chain transgene,
such that the transgenic mouse makes human antibodies.